查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1547723

全球外泌体市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Exosomes Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

预计到2032年，全球外泌体市场需求将从2023年的1.6974亿美元达到近2.2498亿美元的市场规模，2024-2032年研究期间的复合年增长率为3.18%。

外泌体是指含有产生它们的细胞的蛋白质、RNA 和 DNA 的细胞外囊泡。外泌体疗法是用于癌症早期检测的新疗法。从牛奶中提取的外泌体主要用于传递针对乳癌和肺癌的治疗分子。外泌体具有作为药物传递载体的巨大潜力，因为它们具有天然的物质运输特性，例如高生物相容性和内在的长期循环。透过外泌体进行的细胞间通讯被认为参与了癌症、发炎和神经退化性疾病等多种疾病的发病机制。

市场动态

全球癌症发生率的上升，以及外泌体分离和分析程序的技术进步，是预测期内推动外泌体市场的主要因素。此外，外泌体在治疗中的先进应用的增加以及对癌症早期诊断的日益重视，极大地促进了全球外泌体市场的成长。医疗保健支出的增加和与医疗保健相关的意识的增强对全球外泌体市场的成长产生了积极影响。此外，私人和公共机构不断增加的肿瘤学研究和开发，加上主要参与者强大的管道产品，预计将在未来几年为市场创造利润丰厚的机会。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球外泌体市场的各个细分市场进行了包容性评估。外泌体产业的成长和趋势为这项研究提供了整体方法。

市场区隔

外泌体市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按产品分类

  • 试剂盒和试剂
  • 仪器仪表
  • 服务

按工作流程

  • 分离方法（超速离心、珠子免疫捕获、沉淀、过滤等）
  • 下游分析（使用流式细胞仪进行细胞表面标记分析、使用印迹和 Elisa 进行蛋白质分析、使用 Ngs 和 PCR 进行 RNA 分析、使用质谱图进行蛋白质体分析等）

按申请

  • 癌症
  • 神经退化性疾病
  • 心血管疾病
  • 传染病
  • 其他的

按最终用途

  • 製药与生物技术公司
  • 医院和诊断中心
  • 学术及研究机构

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲外泌体市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。外泌体市场的主要参与者包括 Danaher Corporation、Hologic Inc.、Fujifilm Holdings Corporation、Lonza、Miltenyi Biotec、Bio-Techne Corporation、QIAGEN、Thermo Fisher Scientific Inc.、Abcam Plc、RoosterBio Inc.。竞争格局，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：外泌体 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 依工作流程进行市场吸引力分析
    • 市场吸引力分析：依应用分类
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球外泌体市场分析：依产品分类

  • 概述（按产品）
  • 历史和预测数据
  • 按产品分析
  • 试剂盒和试剂
  • 仪器仪表
  • 服务

第 6 章：全球外泌体市场分析：依工作流程

  • 按工作流程概述
  • 历史和预测数据
  • 按工作流程分析
  • 分离方法（超速离心、珠子免疫捕获、沉淀、过滤等）
  • 下游分析（使用流式细胞仪进行细胞表面标记分析、使用印迹和 Elisa 进行蛋白质分析、使用 Ngs 和 PCR 进行 RNA 分析、使用质谱图进行蛋白质体分析等）

第 7 章：全球外泌体市场分析：依应用分类

  • 概述：按应用
  • 历史和预测数据
  • 分析：按应用
  • 癌症
  • 神经退化性疾病
  • 心血管疾病
  • 传染病
  • 其他的

第 8 章：全球外泌体市场分析：依最终用途分类

  • 按最终用途分类的概述
  • 历史和预测数据
  • 按最终用途分析
  • 製药与生物技术公司
  • 医院和诊断中心
  • 学术及研究机构

第 9 章：全球外泌体市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：外泌体公司的竞争格局

  • 外泌体市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Danaher Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Hologic Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Fujifilm Holdings Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Lonza
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Miltenyi Biotec
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bio-Techne Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • QIAGEN
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Thermo Fisher Scientific Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Abcam Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • RoosterBio Inc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11213631

The global demand for Exosomes Market is presumed to reach the market size of nearly USD 224.98 Million by 2032 from USD 169.74 Million in 2023 with a CAGR of 3.18% under the study period 2024-2032.

Exosomes refer to an extracellular vesicle that contains protein, RNA, and DNA of the cells that produce them. Exosome therapy is the new treatment used in the early stage of cancer detection. Exosomes extracted from cow milk are majorly used to deliver therapeutic molecules against breast and lung cancers. Exosomes have huge potential to act like vehicles for drug delivery because they have natural material transportation properties such as high biocompatibility and intrinsic long-term circulation. Intercellular communication through exosomes supposed to be involved in the pathogenesis of a variety of disorders such as cancer, inflammatory and neurodegeneration diseases.

MARKET DYNAMICS

The rising prevalence of cancer cases across the globe, along with technological advancements in exosomes isolation and analytical procedures, are the major factors driving the exosomes market over the forecast period. Moreover, increasing advanced applications of exosomes in therapeutic and the rising emphasis on early diagnosis of cancer are highly contributing to the growth of the global exosomes market. The rising healthcare expenditure and growing awareness related to healthcare creates a positive impact on the growth of the exosomes market globally. Furthermore, increasing research and development in oncology by private and public institutions, coupled with strong pipeline products of key players, are expected to create a lucrative opportunity for the market in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Exosomes. The growth and trends of Exosomes industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Exosomes market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Kits & Reagents
  • Instruments
  • Services

By Workflow

  • Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others)
  • Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others)

By Application

  • Cancer
  • Neurodegenerative Diseases
  • Cardiovascular Diseases
  • Infectious Diseases
  • Others

By End-Use

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostics Centers
  • Academic & Research Institutes

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Exosomes market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Exosomes market include Danaher Corporation, Hologic Inc., Fujifilm Holdings Corporation, Lonza, Miltenyi Biotec, Bio-Techne Corporation, QIAGEN, Thermo Fisher Scientific Inc., Abcam Plc, RoosterBio Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. EXOSOMES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Workflow
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-Use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EXOSOMES MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data
  • 5.3. Analysis By Product
  • 5.4. Kits & Reagents Historic and Forecast Sales By Regions
  • 5.5. Instruments Historic and Forecast Sales By Regions
  • 5.6. Services Historic and Forecast Sales By Regions

6. GLOBAL EXOSOMES MARKET ANALYSIS BY WORKFLOW

  • 6.1. Overview By Workflow
  • 6.2. Historical and Forecast Data
  • 6.3. Analysis By Workflow
  • 6.4. Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others) Historic and Forecast Sales By Regions
  • 6.5. Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others) Historic and Forecast Sales By Regions

7. GLOBAL EXOSOMES MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data
  • 7.3. Analysis By Application
  • 7.4. Cancer Historic and Forecast Sales By Regions
  • 7.5. Neurodegenerative Diseases Historic and Forecast Sales By Regions
  • 7.6. Cardiovascular Diseases Historic and Forecast Sales By Regions
  • 7.7. Infectious Diseases Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL EXOSOMES MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-Use
  • 8.2. Historical and Forecast Data
  • 8.3. Analysis By End-Use
  • 8.4. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
  • 8.5. Hospitals & Diagnostics Centers Historic and Forecast Sales By Regions
  • 8.6. Academic & Research Institutes Historic and Forecast Sales By Regions

9. GLOBAL EXOSOMES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EXOSOMES COMPANIES

  • 10.1. Exosomes Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF EXOSOMES INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Danaher Corporation
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Hologic Inc.
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Fujifilm Holdings Corporation
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Lonza
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Miltenyi Biotec
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Bio-Techne Corporation
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. QIAGEN
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Thermo Fisher Scientific Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Abcam Plc
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. RoosterBio Inc
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Kits & Reagents Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Analysis By Workflow (USD MN)
  • Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others) Market Sales By Geography (USD MN)
  • Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Neurodegenerative Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Hospitals & Diagnostics Centers Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Exosomes Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Exosomes Report
  • Market Research Process
  • Market Research Methodology
  • Global Exosomes Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Workflow
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Kits & Reagents Market Sales By Geography (USD MN)
  • Instruments Market Sales By Geography (USD MN)
  • Services Market Sales By Geography (USD MN)
  • Global Market Analysis By Workflow (USD MN)
  • Isolation Methods (Ultracentrifugation, Immunocapture On Beads, Precipitation, Filtration, Others) Market Sales By Geography (USD MN)
  • Downstream Analysis (Cell Surface Marker Analysis Using Flow Cytometry, Protein Analysis Using Blotting & Elisa, Rna Analysis With Ngs & Pcr, Proteomic Analysis Using Mass Spectroscopy, Others) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Cancer Market Sales By Geography (USD MN)
  • Neurodegenerative Diseases Market Sales By Geography (USD MN)
  • Cardiovascular Diseases Market Sales By Geography (USD MN)
  • Infectious Diseases Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales By Geography (USD MN)
  • Hospitals & Diagnostics Centers Market Sales By Geography (USD MN)
  • Academic & Research Institutes Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.